Doximity Announces Fiscal 2025 Second Quarter Financial Results
Doximity, Inc. Class A (DOCS)
Company Research
Source: Business Wire
Total revenues of $136.8 million, up 20% year-over-yearNet income growth of 44% and adjusted EBITDA growth of 41% year-over-year SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, 2024.“Our clinical workflow tools saw record use in Q2 with over 600,000 unique active prescribers,” said Jeff Tangney, co-founder and CEO of Doximity. “We’re proud to help physicians save time, so they can provide better care for their patients.”Fiscal 2025 Second Quarter Financial HighlightsAll comparisons, unless otherwise noted, are to the three months ended September 30, 2023.Revenue: Revenue of $136.8 million, versus $113.6 million, an increase of 20% year-over-year.Net income and non-GAAP net income: Net income of $44.2 million, versus $30.6 million, representing a margin of 32.3%, versus 26.9%. Non-GAAP net income of $61.1 million, versus $45.6 millio
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- Doximity, Inc. (NASDAQ: DOCS) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $48.00. They now have a "neutral" rating on the stock.MarketBeat
- Zacks.com featured highlights Doximity, Impinj and Innodata [Yahoo! Finance]Yahoo! Finance
- TikTok ‘dermfluencers' have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week [Yahoo! Finance]Yahoo! Finance
- TikTok ‘dermfluencers' have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week [Fortune]Fortune
- Polen U.S. Small Company Growth Strategy Exited Doximity (DOCS) Due to Multiple Factors [Yahoo! Finance]Yahoo! Finance
DOCS
Earnings
- 11/7/24 - Beat
DOCS
Sec Filings
- 11/15/24 - Form 4
- 11/15/24 - Form 4
- 11/14/24 - Form SC
- DOCS's page on the SEC website